ACB
Price
$5.95
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
OGI
Price
$1.88
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
Ad is loading...

ACB vs OGI

Header iconACB vs OGI Comparison
Open Charts ACB vs OGIBanner chart's image
Aurora Cannabis
Price$5.95
Change-$0.00 (-0.00%)
Volume$852.74K
CapitalizationN/A
Organigram Holdings
Price$1.88
Change-$0.00 (-0.00%)
Volume$378.36K
CapitalizationN/A
View a ticker or compare two or three
ACB vs OGI Comparison Chart
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACB vs. OGI commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Buy and OGI is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ACB: $5.95 vs. OGI: $1.88)
Brand notoriety: ACB: Notable vs. OGI: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 101% vs. OGI: 101%
Market capitalization -- ACB: $238.86M vs. OGI: $200.85M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, OGI is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 4 TA indicator(s) are bullish while OGI’s TA Score has 4 bullish TA indicator(s).

  • ACB’s TA Score: 4 bullish, 4 bearish.
  • OGI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACB is a better buy in the short-term than OGI.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а +7.99% price change this week, while OGI (@Pharmaceuticals: Other) price change was +6.82% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

ACB is expected to report earnings on Feb 06, 2025.

OGI is expected to report earnings on Nov 27, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than OGI($201M). OGI YTD gains are higher at: 43.511 vs. ACB (24.947). OGI has higher annual earnings (EBITDA): -195.74M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. OGI (42.3M). OGI has less debt than ACB: OGI (136K) vs ACB (103M). ACB has higher revenues than OGI: ACB (212M) vs OGI (161M).
ACBOGIACB / OGI
Capitalization239M201M119%
EBITDA-1.64B-195.74M836%
Gain YTD24.94743.51157%
P/E RatioN/AN/A-
Revenue212M161M132%
Total Cash149M42.3M352%
Total Debt103M136K75,735%
FUNDAMENTALS RATINGS
ACB vs OGI: Fundamental Ratings
ACB
OGI
OUTLOOK RATING
1..100
1310
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9397
PRICE GROWTH RATING
1..100
5042
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (59) in the null industry is somewhat better than the same rating for ACB (94) in the Pharmaceuticals Other industry. This means that OGI’s stock grew somewhat faster than ACB’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to ACB’s over the last 12 months.

ACB's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as OGI (97) in the null industry. This means that ACB’s stock grew similarly to OGI’s over the last 12 months.

OGI's Price Growth Rating (42) in the null industry is in the same range as ACB (50) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to ACB’s over the last 12 months.

OGI's P/E Growth Rating (97) in the null industry is in the same range as ACB (100) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to ACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBOGI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ACB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been closely correlated with CGC. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
+0.34%
CGC - ACB
82%
Closely correlated
-0.74%
TLRY - ACB
76%
Closely correlated
+2.37%
CRON - ACB
68%
Closely correlated
+0.68%
SNDL - ACB
65%
Loosely correlated
+1.38%
OGI - ACB
52%
Loosely correlated
+1.62%
More

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
+1.62%
SNDL - OGI
67%
Closely correlated
+1.38%
CRON - OGI
63%
Loosely correlated
+0.68%
TLRY - OGI
58%
Loosely correlated
+2.37%
ACB - OGI
52%
Loosely correlated
+0.34%
CGC - OGI
49%
Loosely correlated
-0.74%
More